SELECT * FROM `stock_list` where symbol='WEK' AND exchange = 'FRA' limit 0,1
SELECT * FROM `stock_list` where symbol='WEK' AND exchange = 'FRA' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "WEK" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 Alaunos Therapeutics (FRA:WEK) Shiller PE Ratio
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alaunos Therapeutics Inc (FRA:WEK) » Definitions » Shiller PE Ratio

Alaunos Therapeutics (FRA:WEK) Shiller PE Ratio : (As of May. 01, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Alaunos Therapeutics Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alaunos Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Alaunos Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alaunos Therapeutics Shiller PE Ratio Chart

Alaunos Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alaunos Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alaunos Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Alaunos Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alaunos Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alaunos Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alaunos Therapeutics's Shiller PE Ratio falls into.



Alaunos Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alaunos Therapeutics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Alaunos Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Alaunos Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.072 99.695 -0.093
201406 -0.044 100.560 -0.057
201409 -0.047 100.428 -0.061
201412 -0.073 99.070 -0.095
201503 -0.638 99.621 -0.829
201506 -0.098 100.684 -0.126
201509 -0.125 100.392 -0.161
201512 -0.064 99.792 -0.083
201603 -0.081 100.470 -0.104
201606 -0.899 101.688 -1.144
201609 -0.098 101.861 -0.125
201612 -0.104 101.863 -0.132
201703 -0.140 102.862 -0.176
201706 -0.116 103.349 -0.145
201709 -0.109 104.136 -0.135
201712 -0.110 104.011 -0.137
201803 -0.122 105.290 -0.150
201806 -0.103 106.317 -0.125
201809 -0.111 106.507 -0.135
201812 1.134 105.998 1.385
201903 -0.071 107.251 -0.086
201906 -0.080 108.070 -0.096
201909 -0.390 108.329 -0.466
201912 -0.081 108.420 -0.097
202003 -0.081 108.902 -0.096
202006 -0.080 108.767 -0.095
202009 -0.085 109.815 -0.100
202012 -0.090 109.897 -0.106
202103 -0.084 111.754 -0.097
202106 -0.091 114.631 -0.103
202109 0.000 115.734 0.000
202112 0.000 117.630 0.000
202203 0.000 121.301 0.000
202206 0.000 125.017 0.000
202209 0.000 125.227 0.000
202212 0.000 125.222 0.000
202303 0.000 127.348 0.000
202306 0.000 128.729 0.000
202309 0.000 129.860 0.000
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alaunos Therapeutics  (FRA:WEK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Alaunos Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Alaunos Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alaunos Therapeutics (FRA:WEK) Business Description

Traded in Other Exchanges
Address
8030 El Rio Street, Houston, TX, USA, 77054
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.

Alaunos Therapeutics (FRA:WEK) Headlines

No Headlines